SCHEMBL690291

SCHEMBL690291

CCC(COC(=O)C(C)CS)(COC(=O)C(C)CS)COC(=O)C(C)CS

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.36
ENPEP Q07075 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18289497 0.94 THRB (0.40) THRB
SCHEMBL18289508 0.91 ALDH1A1 (0.35) THRB
SCHEMBL1170960 0.90 ENPEP (0.33) ENPEP
SCHEMBL18289502 0.88 THRB (0.36) THRB
SCHEMBL30610981 0.84 ALDH1A1 (0.38) ENPEP
SCHEMBL1171084 0.84 ENPEP (0.31) ENPEP
SCHEMBL30762100 0.84 ALDH1A1 (0.38) ENPEP
SCHEMBL18289511 0.84 ALDH1A1 (0.42) ENPEP
SCHEMBL8218550 0.83 THRB (0.38) THRB
SCHEMBL8208714 0.80 SMN1; SMN2 (0.39) THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989567-B2 Method for production of water/oil repellent composition and article ASAHI GLASS COMPANY, LIMITED (JP) 2011-08-02 US claimed
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device FUJIFILM CORPORATION (JP) 2026-05-12 US disclosed
EP-3753997-B1 LATENT ADDITIVE AND COMPOSITION CONTAINING LATENT ADDITIVE ADEKA CORP (JP) 2026-05-06 EP disclosed
EP-3819291-B1 OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAME ADEKA CORP (JP) 2026-04-15 EP disclosed
EP-4703778-A1 WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE Dai Nippon Printing Co., Ltd. (JP) 2026-03-04 EP disclosed
US-12565548-B2 Compound, polymerizable composition, and cured product FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
EP-4202505-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM DAINIPPON PRINTING CO LTD (JP) 2026-02-18 EP disclosed
EP-4201667-B1 BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME DAINIPPON PRINTING CO LTD (JP) 2025-12-17 EP disclosed
US-12496802-B2 Barrier film, wavelength conversion sheet using same, backlight and liquid crystal display device DAI NIPPON PRINTING CO., LTD. (JP) 2025-12-16 US disclosed
US-12492293-B2 Multi-component systems for preparing foamed products ARKEMA FRANCE (FR) 2025-12-09 US disclosed
EP-2143739-A1 URETHANE COMPOUND, CURABLE COMPOSITION CONTAINING THE SAME, AND CURED PRODUCT OF THE COMPOSITION Showa Denko K.K. (JP) 2010-01-13 EP disclosed
US-7569327-B2 Curable polymer compound SHOWDA DENKO K.K. (JP) 2009-08-04 US disclosed
EP-2055726-A1 THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Showa Denko K.K. (JP) 2009-05-06 EP disclosed
EP-1629046-B1 CURABLE POLYMER COMPOUND SHOWA DENKO KK (JP) 2008-05-14 EP disclosed
US-7341828-B2 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2008-03-11 US disclosed
US-20070083012-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-04-12 US disclosed
US-20070021571-A1 Curable polymer compound SHOWA DENKO K.K. (JP) 2007-01-25 US disclosed
US-20060079593-A1 Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same SHOWA DENKO K.K. (JP) 2006-04-13 US disclosed
US-20060041053-A1 Color filter black matrix resist composition and carbon black dispersion composition used for the composition SHOWA DENKO K.K. (JP) 2006-02-23 US disclosed
US-20050153231-A1 Thiol compound, photopolymerization initiator composition and photosensitive composition SHOWA DENKO K.K. (JP) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624279-B2 Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device NLRP1, NLRP3, ALAD THRB 1218/4885ENPEP 2350/4885
US-12565548-B2 Compound, polymerizable composition, and cured product SEM1, PSMA1, RER1 THRB 4087/4885ENPEP 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.